Wnt5a/Ror2 promotes vascular smooth muscle cells proliferation via activating PKC
Abstract
Introduction. Abnormal proliferation of vascular smooth muscle cells (VSMCs) can cause various vascular diseases, such as atherosclerosis, restenosis, and pulmonary hypertension. However, the effect and underlying mechanism of Wnt5a on the proliferation of VSMCs remain unclear. Our study aimed to investigate whether Wnt5a/Ror2 promotes vascular smooth muscle cell proliferation via activating protein kinase C (PKC), thereby effectively alleviating vascular proliferative diseases.
Material and methods. The proliferation of HA-VSMC cell line was evaluated by CCK-8, EdU, and Plate clone formation assays. The Wnt5a gene knockdown and overexpression were carried out by standard methods. The interaction between Wnt5a and Ror2 was explored by co-immunoprecipitation. Western blotting and immunofluorescence were used to determine the expression levels of key proteins in VSMCs.
Results. The present study found that the expression of Wnt5a protein increased significantly in the proliferation of VSMCs stimulated by 10% serum in a time-dependent manner. Furthermore, the proliferative rate of VSMCs overexpressing Wnt5a was dramatically accelerated, whereas Wnt5a knockdown using siWnt5a reversed thisproliferative effect. Wnt5a up-regulated the expression of receptor tyrosine kinase-like orphan receptor 2 (Ror2) by binding to it. Further studies indicated that Wnt5a induces the PKC expression in VSMCs and knockdown of Wnt5a or Ror2 could inhibit PKC phosphorylation.
Conclusions. Wnt5a could effectively promote the proliferation of VSMCs, which might be related to the binding of Wnt5a and Ror2 to activate PKC.
Keywords: vascular smooth muscle cellsWnt5aRor2PKCcell proliferation
References
- Chistiakov DA, Orekhov AN, Bobryshev YV. Vascular smooth muscle cell in atherosclerosis. Acta Physiol (Oxf). 2015; 214(1): 33–50.
- Wang D, Uhrin P, Mocan A, et al. Vascular smooth muscle cell proliferation as a therapeutic target. Part 1: molecular targets and pathways. Biotechnol Adv. 2018; 36(6): 1586–1607.
- Wodarz A, Nusse R. Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol. 1998; 14: 59–88.
- Shi YN, Zhu N, Liu C, et al. Wnt5a and its signaling pathway in angiogenesis. Clin Chim Acta. 2017; 471: 263–269.
- Kumawat K, Gosens R. WNT-5A: signaling and functions in health and disease. Cell Mol Life Sci. 2016; 73(3): 567–587.
- Christman 2nd MA, Goetz DJ, Dickerson E, et al. Wnt5a is expressed in murine and human atherosclerotic lesions. Am J Physiol Heart Circ Physiol. 2008; 294(6): H2864–H2870.
- Ackers I, Szymanski C, Duckett KJ, et al. Blocking Wnt5a signaling decreases CD36 expression and foam cell formation in atherosclerosis. Cardiovasc Pathol. 2018; 34: 1–8.
- Yang L, Chu Y, Wang Y, et al. siRNA-mediated silencing of Wnt5a regulates inflammatory responses in atherosclerosis through the MAPK/NF-κB pathways. Int J Mol Med. 2014; 34(4): 1147–1152.
- Nishita M, Qiao S, Miyamoto M, et al. Role of Wnt5a-Ror2 signaling in morphogenesis of the metanephric mesenchyme during ureteric budding. Mol Cell Biol. 2014; 34(16): 3096–3105.
- He F, Xiong W, Yu X, et al. Wnt5a regulates directional cell migration and cell proliferation via Ror2-mediated noncanonical pathway in mammalian palate development. Development. 2008; 135(23): 3871–3879.
- Takiguchi G, Nishita M, Kurita K, et al. Wnt5a-Ror2 signaling in mesenchymal stem cells promotes proliferation of gastric cancer cells by activating CXCL16-CXCR6 axis. Cancer Sci. 2016; 107(3): 290–297.
- Yang J, Zhang K, Wu J, et al. Wnt5a increases properties of lung cancer stem cells and resistance to cisplatin through activation of Wnt5a/PCK signaling pathway. Stem Cells Int. 2016; 2016: 1690896.
- Rieger ME, Zhou B, Solomon N, et al. p300/β-catenin interactions regulate adult progenitor cell differentiation downstream of wnt5a/protein kinase c (PKC). J Biol Chem. 2016; 291(12): 6569–6582.
- Dissanayake SK, Wade M, Johnson CE, et al. The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition. J Biol Chem. 2007; 282(23): 17259–17271.
- Isakov N. Protein kinase C (PKC) isoforms in cancer, tumor promotion and tumor suppression. Semin Cancer Biol. 2018; 48: 36–52.
- Lu Q, Davel AP, McGraw AP, et al. PKCδ mediates mineralocorticoid receptor activation by angiotensin II to modulate smooth muscle cell function. Endocrinology. 2019; 160(9): 2101–2114.
- Cerpa W, Latorre-Esteves E, Barria A. RoR2 functions as a noncanonical Wnt receptor that regulates NMDAR-mediated synaptic transmission. Proc Natl Acad Sci U S A. 2015; 112(15): 4797–4802.
- Zhang CJ, Zhu N, Liu Z, et al. Wnt5a/Ror2 pathway contributes to the regulation of cholesterol homeostasis and inflammatory response in atherosclerosis. Biochim Biophys Acta Mol Cell Biol Lipids. 2020; 1865(2): 158547.
- Owens GK, et al. Regulation of differentiation of vascular smooth muscle cells . Physiol Rev. 1995; 75(3): 487–517.
- Gordon D, Schwartz SM. Replication of arterial smooth muscle cells in hypertension and atherosclerosis. Am J Cardiol. 1987; 59(2): 44A–48A.
- Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev. 2004; 84(3): 767–801.
- Smith SA, Newby AC, Bond M. Ending restenosis: inhibition of vascular smooth muscle cell proliferation by cAMP. Cells. 2019; 8(11): 1447.
- Wadey K, Lopes J, Bendeck M, et al. Role of smooth muscle cells in coronary artery bypass grafting failure. Cardiovasc Res. 2018; 114(4): 601–610.
- Bhatt PM, Lewis CJ, House DL, et al. Increased Wnt5a mRNA expression in advanced atherosclerotic lesions, and oxidized LDL treated human monocyte-derived macrophages. Open Circ Vasc J. 2012; 5: 1–7.
- Bhatt PM, Malgor R. Wnt5a: a player in the pathogenesis of atherosclerosis and other inflammatory disorders. Atherosclerosis. 2014; 237(1): 155–162.
- Asem MS, Buechler S, Wates RB, et al. Wnt5a signaling in cancer. Cancers (Basel). 2016; 8(9): 79.
- Ackers I, Szymanski C, Silver MJ, et al. Oxidized low-density lipoprotein induces WNT5A signaling activation in THP-1 derived macrophages and a human aortic vascular smooth muscle cell line. Front Cardiovasc Med. 2020; 7: 567837.
- Xing Ap, Du Yc, Hu Xy, et al. Cigarette smoke extract stimulates rat pulmonary artery smooth muscle cell proliferation via PKC-PDGFB signaling. J Biomed Biotechnol. 2012; 2012: 534384.
- Zhou H, Wang Y, Zhou Q, et al. Down-regulation of protein kinase c-ε by prolonged incubation with PMA inhibits the proliferation of vascular smooth muscle cells. Cell Physiol Biochem. 2016; 40(1-2): 379–390.
- Jain M, Singh A, Singh V, et al. Involvement of interleukin-1 receptor-associated kinase-1 in vascular smooth muscle cell proliferation and neointimal formation after rat carotid injury. Arterioscler Thromb Vasc Biol. 2015; 35(6): 1445–1455.
- Jiang R, Shi Y, Zeng C, et al. Protein kinase Cα stimulates hypoxia‑induced pulmonary artery smooth muscle cell proliferation in rats through activating the extracellular signal‑regulated kinase 1/2 pathway. Mol Med Rep. 2017; 16(5): 6814–6820.
- Yang J, Han Yu, Sun H, et al. (-)-Epigallocatechin gallate suppresses proliferation of vascular smooth muscle cells induced by high glucose by inhibition of PKC and ERK1/2 signalings. J Agric Food Chem. 2011; 59(21): 11483–11490.
- Qin Li, Yin YT, Zheng FJ, et al. WNT5A promotes stemness characteristics in nasopharyngeal carcinoma cells leading to metastasis and tumorigenesis. Oncotarget. 2015; 6(12): 10239–10252.
